Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2
© 2024. The Author(s)..
The coronavirus disease 2019 (COVID-19) pandemic continues to represent a global public health issue. The viral main protease (Mpro) represents one of the most attractive targets for the development of antiviral drugs. Herein we report peptidyl nitroalkenes exhibiting enzyme inhibitory activity against Mpro (Ki: 1-10 μM) good anti-SARS-CoV-2 infection activity in the low micromolar range (EC50: 1-12 μM) without significant toxicity. Additional kinetic studies of compounds FGA145, FGA146 and FGA147 show that all three compounds inhibit cathepsin L, denoting a possible multitarget effect of these compounds in the antiviral activity. Structural analysis shows the binding mode of FGA146 and FGA147 to the active site of the protein. Furthermore, our results illustrate that peptidyl nitroalkenes are effective covalent reversible inhibitors of the Mpro and cathepsin L, and that inhibitors FGA145, FGA146 and FGA147 prevent infection against SARS-CoV-2.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
Communications chemistry - 7(2024), 1 vom: 18. Jan., Seite 15 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Medrano, Francisco J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 21.01.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1038/s42004-024-01104-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36728913X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36728913X | ||
| 003 | DE-627 | ||
| 005 | 20240121231939.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240119s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s42004-024-01104-7 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1266.xml |
| 035 | |a (DE-627)NLM36728913X | ||
| 035 | |a (NLM)38238420 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Medrano, Francisco J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2 |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 21.01.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2024. The Author(s). | ||
| 520 | |a The coronavirus disease 2019 (COVID-19) pandemic continues to represent a global public health issue. The viral main protease (Mpro) represents one of the most attractive targets for the development of antiviral drugs. Herein we report peptidyl nitroalkenes exhibiting enzyme inhibitory activity against Mpro (Ki: 1-10 μM) good anti-SARS-CoV-2 infection activity in the low micromolar range (EC50: 1-12 μM) without significant toxicity. Additional kinetic studies of compounds FGA145, FGA146 and FGA147 show that all three compounds inhibit cathepsin L, denoting a possible multitarget effect of these compounds in the antiviral activity. Structural analysis shows the binding mode of FGA146 and FGA147 to the active site of the protein. Furthermore, our results illustrate that peptidyl nitroalkenes are effective covalent reversible inhibitors of the Mpro and cathepsin L, and that inhibitors FGA145, FGA146 and FGA147 prevent infection against SARS-CoV-2 | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a de la Hoz-Rodríguez, Sergio |e verfasserin |4 aut | |
| 700 | 1 | |a Martí, Sergio |e verfasserin |4 aut | |
| 700 | 1 | |a Arafet, Kemel |e verfasserin |4 aut | |
| 700 | 1 | |a Schirmeister, Tanja |e verfasserin |4 aut | |
| 700 | 1 | |a Hammerschmidt, Stefan J |e verfasserin |4 aut | |
| 700 | 1 | |a Müller, Christin |e verfasserin |4 aut | |
| 700 | 1 | |a González-Martínez, Águeda |e verfasserin |4 aut | |
| 700 | 1 | |a Santillana, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Ziebuhr, John |e verfasserin |4 aut | |
| 700 | 1 | |a Romero, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Zimmer, Collin |e verfasserin |4 aut | |
| 700 | 1 | |a Weldert, Annabelle |e verfasserin |4 aut | |
| 700 | 1 | |a Zimmermann, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Lodola, Alessio |e verfasserin |4 aut | |
| 700 | 1 | |a Świderek, Katarzyna |e verfasserin |4 aut | |
| 700 | 1 | |a Moliner, Vicent |e verfasserin |4 aut | |
| 700 | 1 | |a González, Florenci V |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Communications chemistry |d 2018 |g 7(2024), 1 vom: 18. Jan., Seite 15 |w (DE-627)NLM28508335X |x 2399-3669 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2024 |g number:1 |g day:18 |g month:01 |g pages:15 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s42004-024-01104-7 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2024 |e 1 |b 18 |c 01 |h 15 | ||